Literature DB >> 17656431

Sustained CGRP1 receptor stimulation modulates development of EC coupling by cAMP/PKA signalling pathway in mouse skeletal myotubes.

Guillermo Avila1, Citlalli I Aguilar, Roberto Ramos-Mondragón.   

Abstract

We investigated modulation of excitation-contraction (EC) coupling by calcitonin gene-related peptide (CGRP), which is released by motorneurons during neuromuscular transmission. Mouse skeletal myotubes were cultured either under control conditions or in the presence of 100 nm CGRP ( approximately 4-72 h). T- and L-type Ca(2+) currents, immobilization resistant charge movement, and intracellular Ca(2+) transients were characterized in whole-cell patch-clamp experiments. CGRP treatment increased the amplitude of voltage-gated Ca(2+) release ((DeltaF/F)(max)) approximately 75-350% and moderately increased both maximal L-current conductance (G(max)) and charge movement (Q(max)). In contrast, CGRP treatment did not affect their corresponding voltage dependence of activation (V(1/2) and k) or T-current density. CGRP treatment enhanced voltage-gated Ca(2+) release in approximately 4 h, whereas the effect on L-channel magnitude took longer to develop ( approximately 24 h), suggesting that short-term potentiation of EC coupling may lead to subsequent long-term up-regulation of DHPR expression. CGRP treatment also drastically increased caffeine-induced Ca(2+) release in approximately 4 h ( approximately 400%). Thus, short-term potentiation of EC coupling is due to an increase in sarcoplasmic reticulum Ca(2+) content. Both application of a phosphodiesterase inhibitor (papaverine) and a membrane-permeant cAMP analogue (Db-cAMP) produced a similar potentiation of EC coupling. Conversely, this potentiation was prevented by pretreatment with either CGRP1 receptor antagonist (CGRP(8-37)) or a PKA inhibitor (H-89). Thus, CGRP acts through CGRP1 receptors and the cAMP/PKA signalling pathway to enhance voltage-gated Ca(2+) release. Effects of CGRP on both EC coupling and L-channels were attenuated at later times during myotube differentiation. Therefore, we conclude that CGRP accelerates maturation of EC coupling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656431      PMCID: PMC2277057          DOI: 10.1113/jphysiol.2007.137687

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  41 in total

1.  Developmentally regulated expression of calcitonin gene-related peptide at mammalian neuromuscular junction.

Authors:  M Matteoli; S Balbi; C Sala; B Chini; M Cimino; M Vitadello; G Fumagalli
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

2.  Involvement of dihydropyridine receptors in excitation-contraction coupling in skeletal muscle.

Authors:  E Rios; G Brum
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

3.  Effect of calcitonin gene-related peptide on contraction of striated muscle in the mouse.

Authors:  K Takami; Y Kawai; S Uchida; M Tohyama; Y Shiotani; H Yoshida; P C Emson; S Girgis; C J Hillyard; I MacIntyre
Journal:  Neurosci Lett       Date:  1985-09-30       Impact factor: 3.046

4.  Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA.

Authors:  T Tanabe; K G Beam; J A Powell; S Numa
Journal:  Nature       Date:  1988-11-10       Impact factor: 49.962

5.  Effect of calcitonin gene-related peptide on the cyclic AMP level of isolated mouse diaphragm.

Authors:  K Takami; K Hashimoto; S Uchida; M Tohyama; H Yoshida
Journal:  Jpn J Pharmacol       Date:  1986-11

6.  Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37).

Authors:  T Chiba; A Yamaguchi; T Yamatani; A Nakamura; T Morishita; T Inui; M Fukase; T Noda; T Fujita
Journal:  Am J Physiol       Date:  1989-02

7.  Release of calcitonin gene-related peptide-like immunoreactive substance from neuromuscular junction by nerve excitation and its action on striated muscle.

Authors:  S Uchida; H Yamamoto; S Iio; N Matsumoto; X B Wang; N Yonehara; Y Imai; R Inoki; H Yoshida
Journal:  J Neurochem       Date:  1990-03       Impact factor: 5.372

8.  Calcitonin gene-related peptide, a peptide present in spinal cord motoneurons, increases the number of acetylcholine receptors in primary cultures of chick embryo myotubes.

Authors:  B Fontaine; A Klarsfeld; T Hökfelt; J P Changeux
Journal:  Neurosci Lett       Date:  1986-10-30       Impact factor: 3.046

9.  Short term and long term effects of beta-adrenergic effectors and cyclic AMP on nitrendipine-sensitive voltage-dependent Ca2+ channels of skeletal muscle.

Authors:  A Schmid; J F Renaud; M Lazdunski
Journal:  J Biol Chem       Date:  1985-10-25       Impact factor: 5.157

10.  Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells.

Authors:  C Mulle; P Benoit; C Pinset; M Roa; J P Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

View more
  9 in total

Review 1.  β-Adrenergic modulation of skeletal muscle contraction: key role of excitation-contraction coupling.

Authors:  Simeon P Cairns; Fabio Borrani
Journal:  J Physiol       Date:  2015-11-01       Impact factor: 5.182

2.  Chronic atrial ionic remodeling by aldosterone: potentiation of L-type Ca2+ channels and its arrhythmogenic significance.

Authors:  Erick B Ríos-Pérez; Maricela García-Castañeda; Adrián Monsalvo-Villegas; Guillermo Avila
Journal:  Pflugers Arch       Date:  2016-09-15       Impact factor: 3.657

3.  G protein-coupled receptor signaling via Src kinase induces endogenous human transient receptor potential vanilloid type 6 (TRPV6) channel activation.

Authors:  Jennifer Spehr; Lian Gelis; Markus Osterloh; Sonja Oberland; Hanns Hatt; Marc Spehr; Eva M Neuhaus
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

4.  In vivo expression of G-protein beta1gamma2 dimer in adult mouse skeletal muscle alters L-type calcium current and excitation-contraction coupling.

Authors:  Norbert Weiss; Claude Legrand; Sandrine Pouvreau; Hicham Bichraoui; Bruno Allard; Gerald W Zamponi; Michel De Waard; Vincent Jacquemond
Journal:  J Physiol       Date:  2010-06-14       Impact factor: 5.182

5.  Calcitonin gene-related peptide restores disrupted excitation-contraction coupling in myotubes expressing central core disease mutations in RyR1.

Authors:  Ana Victoria Vega; Roberto Ramos-Mondragón; Aida Calderón-Rivera; Angel Zarain-Herzberg; Guillermo Avila
Journal:  J Physiol       Date:  2011-08-08       Impact factor: 5.182

6.  Role of central calcitonin gene-related peptide (CGRP) in locomotor and anxiety- and depression-like behaviors in two mouse strains exhibiting a CGRP-dependent difference in thermal pain sensitivity.

Authors:  Ara Schorscher-Petcu; Jean-Sébastien Austin; Jeffrey S Mogil; Rémi Quirion
Journal:  J Mol Neurosci       Date:  2009-04-18       Impact factor: 3.444

7.  Effects of caffeine on metabolism and mitochondria biogenesis in rhabdomyosarcoma cells compared with 2,4-dinitrophenol.

Authors:  Roger A Vaughan; Randi Garcia-Smith; Marco Bisoffi; Kristina A Trujillo; Carole A Conn
Journal:  Nutr Metab Insights       Date:  2012-09-13

8.  Characterization of the vagal motor neurons projecting to the Guinea pig airways and esophagus.

Authors:  Alice E McGovern; Stuart B Mazzone
Journal:  Front Neurol       Date:  2010-12-17       Impact factor: 4.003

9.  α-Calcitonin gene-related peptide inhibits autophagy and calpain systems and maintains the stability of neuromuscular junction in denervated muscles.

Authors:  Juliano Machado; Wilian A Silveira; Dawit A Gonçalves; Aline Zanatta Schavinski; Muzamil M Khan; Neusa M Zanon; Mauricio Berriel Diaz; Rüdiger Rudolf; Isis C Kettelhut; Luiz C Navegantes
Journal:  Mol Metab       Date:  2019-07-03       Impact factor: 7.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.